These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 31249490)

  • 1. Do Disruptions in the Circadian Timing System Contribute to Autonomic Dysfunction in Huntington's Disease?
    Park S; Colwell CS
    Yale J Biol Med; 2019 Jun; 92(2):291-303. PubMed ID: 31249490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian dysfunction in the Q175 model of Huntington's disease: Network analysis.
    Smarr B; Cutler T; Loh DH; Kudo T; Kuljis D; Kriegsfeld L; Ghiani CA; Colwell CS
    J Neurosci Res; 2019 Dec; 97(12):1606-1623. PubMed ID: 31359503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Dysautonomia in Huntington's Disease.
    Abildtrup M; Shattock M
    J Huntingtons Dis; 2013; 2(3):251-61. PubMed ID: 25062674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic alterations in Huntington's disease patients: comparison with genetic rodent models.
    van Wamelen DJ; Aziz NA; Roos RA; Swaab DF
    J Neuroendocrinol; 2014 Nov; 26(11):761-75. PubMed ID: 25074766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-Restricted Feeding Improves Circadian Dysfunction as well as Motor Symptoms in the Q175 Mouse Model of Huntington's Disease.
    Wang HB; Loh DH; Whittaker DS; Cutler T; Howland D; Colwell CS
    eNeuro; 2018; 5(1):. PubMed ID: 29302618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocardiovascular deficits in the Q175 mouse model of Huntington's disease.
    Cutler TS; Park S; Loh DH; Jordan MC; Yokota T; Roos KP; Ghiani CA; Colwell CS
    Physiol Rep; 2017 Jun; 5(11):. PubMed ID: 28576852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian-based Treatment Strategy Effective in the BACHD Mouse Model of Huntington's Disease.
    Whittaker DS; Loh DH; Wang HB; Tahara Y; Kuljis D; Cutler T; Ghiani CA; Shibata S; Block GD; Colwell CS
    J Biol Rhythms; 2018 Oct; 33(5):535-554. PubMed ID: 30084274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early and progressive circadian abnormalities in Huntington's disease sheep are unmasked by social environment.
    Morton AJ; Rudiger SR; Wood NI; Sawiak SJ; Brown GC; Mclaughlan CJ; Kuchel TR; Snell RG; Faull RL; Bawden CS
    Hum Mol Genet; 2014 Jul; 23(13):3375-83. PubMed ID: 24488771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian and sleep disorder in Huntington's disease.
    Morton AJ
    Exp Neurol; 2013 May; 243():34-44. PubMed ID: 23099415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian rhythm and autonomic dysfunction in presymptomatic and early Huntington's disease.
    Bellosta Diago E; Pérez Pérez J; Santos Lasaosa S; Viloria Alebesque A; Martínez Horta S; Kulisevsky J; López Del Val J
    Parkinsonism Relat Disord; 2017 Nov; 44():95-100. PubMed ID: 28935191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blue light therapy improves circadian dysfunction as well as motor symptoms in two mouse models of Huntington's disease.
    Wang HB; Whittaker DS; Truong D; Mulji AK; Ghiani CA; Loh DH; Colwell CS
    Neurobiol Sleep Circadian Rhythms; 2017 Jan; 2():39-52. PubMed ID: 31236494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic and Limbic System Changes in Huntington's Disease.
    Petersén A; Gabery S
    J Huntingtons Dis; 2012; 1(1):5-16. PubMed ID: 25063186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep Disorders and Circadian Disruption in Huntington's Disease.
    Saade-Lemus S; Videnovic A
    J Huntingtons Dis; 2023; 12(2):121-131. PubMed ID: 37424473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using Actiwatch to monitor circadian rhythm disturbance in Huntington' disease: A cautionary note.
    Townhill J; Hughes AC; Thomas B; Busse ME; Price K; Dunnett SB; Hastings MH; Rosser AE
    J Neurosci Methods; 2016 May; 265():13-8. PubMed ID: 26774754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Q175 mouse model of Huntington's disease shows gene dosage- and age-related decline in circadian rhythms of activity and sleep.
    Loh DH; Kudo T; Truong D; Wu Y; Colwell CS
    PLoS One; 2013; 8(7):e69993. PubMed ID: 23936129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysfunctions in circadian behavior and physiology in mouse models of Huntington's disease.
    Kudo T; Schroeder A; Loh DH; Kuljis D; Jordan MC; Roos KP; Colwell CS
    Exp Neurol; 2011 Mar; 228(1):80-90. PubMed ID: 21184755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive gene dose-dependent disruption of the methamphetamine-sensitive circadian oscillator-driven rhythms in a knock-in mouse model of Huntington's disease.
    Ouk K; Aungier J; Morton AJ
    Exp Neurol; 2016 Dec; 286():69-82. PubMed ID: 27646506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep, Circadian Rhythms, and Cognitive Dysfunction in Huntington's Disease.
    Fitzgerald ES; Stout JC; Glikmann-Johnston Y; Anderson C; Jackson ML
    J Huntingtons Dis; 2023; 12(3):293-304. PubMed ID: 37599535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.
    Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB
    J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'The clocks that time us'--circadian rhythms in neurodegenerative disorders.
    Videnovic A; Lazar AS; Barker RA; Overeem S
    Nat Rev Neurol; 2014 Dec; 10(12):683-93. PubMed ID: 25385339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.